Back
Reviva Pharmaceuticals Holdings Quote, Financials, Valuation and Earnings
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
28
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.21
Seasonality Move:
-14.71%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Reviva Pharmaceuticals Holdings Price Quote
$1.21
-0.04 (-3.2%)
(Updated: November 14, 2024 at 5:55 PM ET)
Reviva Pharmaceuticals Holdings Key Stats
Sell
28
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Day range:
$1.17 - $1.45
52-week range:
$0.60 - $6.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
1.6M
Avg. volume:
515.5K
1-year change:
-79.3%
Market cap:
$43.7M
Revenue:
$0
EPS:
$-1.3
How Much Does Reviva Pharmaceuticals Holdings Make?
Data Unavailable
Is Reviva Pharmaceuticals Holdings Growing As A Company?
Data Unavailable
Reviva Pharmaceuticals Holdings Stock Price Performance
-
Did Reviva Pharmaceuticals Holdings Stock Go Up Last Month?
Reviva Pharmaceuticals Holdings share price went up by 2.46% last month -
Did RVPH's Share Price Rise Over The Last Year?
RVPH share price fell by -79.3% over the past 1 year
What Is Reviva Pharmaceuticals Holdings 52-Week High & Low?
-
What Is Reviva Pharmaceuticals Holdings’s 52-Week High Share Price?
Reviva Pharmaceuticals Holdings has traded as high as $6.22 over the past 52 weeks -
What Is Reviva Pharmaceuticals Holdings’s 52-Week Low Share Price?
Reviva Pharmaceuticals Holdings has traded as low as $0.60 over the past 52 weeks
Reviva Pharmaceuticals Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reviva Pharmaceuticals Holdings?
-
How Much Debt Does Reviva Pharmaceuticals Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reviva Pharmaceuticals Holdings Have?
Cash and short term investments quarterly total is $6.2M -
What Is Reviva Pharmaceuticals Holdings’s Book Value Per Share?
Book value per share is -0.20
Is Reviva Pharmaceuticals Holdings Cash Flow Positive?
-
What Is RVPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$35.3M -
What Is Reviva Pharmaceuticals Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $30.3M -
What Is Reviva Pharmaceuticals Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Reviva Pharmaceuticals Holdings Return On Invested Capital
Data Unavailable
Reviva Pharmaceuticals Holdings Earnings Date & Stock Price
-
What Is Reviva Pharmaceuticals Holdings's Stock Price Today?
A single share of RVPH can be purchased today for 1.25 -
What Is Reviva Pharmaceuticals Holdings’s Stock Symbol?
Reviva Pharmaceuticals Holdings trades on the nasdaq under the ticker symbol: RVPH -
When Is Reviva Pharmaceuticals Holdings’s Next Earnings Date?
The next quarterly earnings date for Reviva Pharmaceuticals Holdings is scheduled on November 14, 2024 -
When Is RVPH's next ex-dividend date?
Reviva Pharmaceuticals Holdings's next ex-dividend date is November 14, 2024 -
How To Buy Reviva Pharmaceuticals Holdings Stock?
You can buy Reviva Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reviva Pharmaceuticals Holdings Competitors
-
Who Are Reviva Pharmaceuticals Holdings's Competitors?
Below is a list of companies who compete with Reviva Pharmaceuticals Holdings or are related in some way:
Reviva Pharmaceuticals Holdings Dividend Yield
-
What Is RVPH Dividend Yield?
Reviva Pharmaceuticals Holdings’s dividend yield currently is 0% -
What Is Reviva Pharmaceuticals Holdings’s Payout Ratio?
Reviva Pharmaceuticals Holdings’s payout ratio is 0% -
When Did Reviva Pharmaceuticals Holdings Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Reviva Pharmaceuticals Holdings’s Dividend Per Share?
Reviva Pharmaceuticals Holdings pays a dividend of $0.00 per share
Reviva Pharmaceuticals Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.63% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 15.20 |
| Upside from Last Price: | 1116% |